Takeda Pharmaceutical Co. Ltd. - Ebitda Interest Coverage

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.

The item "Ebitda-Interest-Coverage" stands at 4.18 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Ebitda Interest Coverage" stands at 4.18. This represents a decrease of -10.46 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -20.02 percent compared to the value the year prior.
The 1 year change in percent is -20.02.
The 3 year change in percent is -29.19.

The Serie's long term average value is 5.26. It's latest available value, on 09/30/2025, is 20.66 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is -32.07%.